Katherine Kurnit

机构：University of Chicago

发表论文 1 篇 · 总被引 2 次 · h-index 1

代表论文

• Phase 1 basket study of telisotuzumab adizutecan (Temab-A, ABBV-400), a c-Met protein–targeting antibody-drug conjugate: Results from patients with platinum-resistant ovarian/primary peritoneal/fallopian tube cancer (PROC). (2026 · Journal of Clinical Oncology · 被引 2)